Suchergebnisse
IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth
Shares of IRIDEX Corporation IRIX have gained 3.6% since the company reported earnings for the quarter ended April 4, 2026, outperforming the S&P 500 index’s 0.6% increase over the same period
